Portfolio
2
companies
B-Secur
B-Secur develops ECG technology and algorithms for consumer and medical devices.
Neurovalens
Neurovalens creates wearable devices that stimulate the brain to address metabolic and health issues.
Eva Tarasova
Investment Director
The financing round was led by First Capital Ventures with participation from existing investors.
"We are delighted to welcome First Capital Ventures as our latest and first U.S. investor alongside the continued commitment from our existing investor base."
Kernel Capital increased its backing alongside Accelerated Digital Ventures, Wharton Asset Management, and Clarendon Fund Managers.
"We are delighted to receive this injection of investment from Kernel and our other investors so we can continue our work with existing customers and advance new customer applications."
The Belfast-based health technology firm secured Series A backing from investors including Wharton Asset Management and IQ Capital to advance its neurological research and medical trials.
"We are delighted to receive this latest wave of funding, it will enable us to continue to lead the way in developing non-invasive neuro-stimulation technology and will propel our work to a whole new level,"
